CBX4 and adenocarcinoma: Using a score of 8 as cutoff, 53.8% of the adenocarcinoma samples demonstrated a high level of CBX4 protein, whereas only 14.1% of the non-neoplastic colon tissues showed high expression (p < 0.01).